These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25302720)

  • 1. Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel.
    Alexander M; King J; Bajel A; Doecke C; Fox P; Lingaratnam S; Mellor JD; Nicholson L; Roos I; Saunders T; Wilkes J; Zielinski R; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    Intern Med J; 2014 Oct; 44(10):1018-26. PubMed ID: 25302720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe handling of hazardous drugs.
    Polovich M
    Online J Issues Nurs; 2004 Sep; 9(3):6. PubMed ID: 15482092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe handling of monoclonal antibodies: Too large to be hazardous?
    de Lemos ML; Badry N; Kletas V; Fabbro J; Tew A
    J Oncol Pharm Pract; 2018 Apr; 24(3):218-220. PubMed ID: 29284346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the evidence for occupational exposure risks to novel anticancer agents - A focus on monoclonal antibodies.
    King J; Alexander M; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    J Oncol Pharm Pract; 2016 Feb; 22(1):121-34. PubMed ID: 25227230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.
    Alexander M; King J; Lingaratnam S; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    J Oncol Pharm Pract; 2016 Apr; 22(2):219-27. PubMed ID: 25398311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncology Nursing Society Position. Ensuring Healthcare Worker Safety When Handling Hazardous Drugs.
    Oncol Nurs Forum; 2015 May; 42(3):217-8. PubMed ID: 25901373
    [No Abstract]   [Full Text] [Related]  

  • 7. Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure.
    Chang J; Leong RW
    Expert Opin Biol Ther; 2014 Jan; 14(1):27-36. PubMed ID: 24206020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIOSH safe handling of hazardous drugs guidelines becomes state law.
    Eisenberg S
    J Infus Nurs; 2012; 35(5):316-9. PubMed ID: 22955153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings.
    Ryan M; Lam N; Wright K; Siderov J
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):723-730. PubMed ID: 36899469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe handling and administration of MABS: the guidance.
    McGowan D
    Br J Nurs; 2015 Sep; 24(16 Suppl 1):S14-20. PubMed ID: 26946647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines.
    Polovich M; Martin S
    Oncol Nurs Forum; 2011 Nov; 38(6):718-26. PubMed ID: 22037334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries.
    Mathias PI; MacKenzie BA; Toennis CA; Connor TH
    J Oncol Pharm Pract; 2019 Jan; 25(1):148-162. PubMed ID: 28841099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies safety and occupational hazard: Current practice in Australia.
    Kirsa S
    J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():29. PubMed ID: 26991681
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance with safe handling guidelines of antineoplastic drugs in Jordanian hospitals.
    Al-Azzam SI; Awawdeh BT; Alzoubi KH; Khader YS; Alkafajei AM
    J Oncol Pharm Pract; 2015 Feb; 21(1):3-9. PubMed ID: 24399836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are your concerns regarding safe handling of chemotherapy?
    Eisenberg S
    ONS Connect; 2008 Aug; 23(8):15. PubMed ID: 18767568
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of adherence to safe handling practices for antineoplastic drugs: A survey of hospital nurses.
    Silver SR; Steege AL; Boiano JM
    J Occup Environ Hyg; 2016; 13(3):203-12. PubMed ID: 26556549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review of Control Measures to Reduce Hazardous Drug Exposure for Health Care Workers.
    Crickman R; Finnell D
    J Nurs Care Qual; 2016; 31(2):183-90. PubMed ID: 26417920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing workplace compliance with handling of antineoplastic agents.
    Gambrell J; Moore S
    Clin J Oncol Nurs; 2006 Aug; 10(4):473-7. PubMed ID: 16927900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse Adherence to Safe-Handling Practices: Observation Versus Self-Assessment.
    Colvin CM; Karius D; Albert NM
    Clin J Oncol Nurs; 2016 Dec; 20(6):617-622. PubMed ID: 27857252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.